These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

321 related items for PubMed ID: 11162416

  • 1. Onset of bronchodilation of budesonide/formoterol vs. salmeterol/fluticasone in single inhalers.
    Palmqvist M, Arvidsson P, Beckman O, Peterson S, Lötvall J.
    Pulm Pharmacol Ther; 2001; 14(1):29-34. PubMed ID: 11162416
    [Abstract] [Full Text] [Related]

  • 2. Budesonide/formoterol in a single inhaler rapidly relieves methacholine-induced moderate-to-severe bronchoconstriction.
    van der Woude HJ, Boorsma M, Bergqvist PB, Winter TH, Aalbers R.
    Pulm Pharmacol Ther; 2004; 17(2):89-95. PubMed ID: 15123230
    [Abstract] [Full Text] [Related]

  • 3. Adjustable maintenance dosing with budesonide/formoterol compared with fixed-dose salmeterol/fluticasone in moderate to severe asthma.
    Aalbers R, Backer V, Kava TT, Omenaas ER, Sandström T, Jorup C, Welte T.
    Curr Med Res Opin; 2004; 20(2):225-40. PubMed ID: 15006018
    [Abstract] [Full Text] [Related]

  • 4. Fast onset of effect of budesonide/formoterol versus salmeterol/fluticasone and salbutamol in patients with chronic obstructive pulmonary disease and reversible airway obstruction.
    Lindberg A, Szalai Z, Pullerits T, Radeczky E.
    Respirology; 2007 Sep; 12(5):732-9. PubMed ID: 17875063
    [Abstract] [Full Text] [Related]

  • 5. Early bronchodilatory effects of budesonide/formoterol pMDI compared with fluticasone/salmeterol DPI and albuterol pMDI: 2 randomized controlled trials in adults with persistent asthma previously treated with inhaled corticosteroids.
    Hampel FC, Martin P, Mezzanotte WS.
    J Asthma; 2008 May; 45(4):265-72. PubMed ID: 18446589
    [Abstract] [Full Text] [Related]

  • 6. Treatment comparison of budesonide/formoterol with salmeterol/fluticasone propionate in adults aged > or =16 years with asthma: post hoc analysis of a randomized, double-blind study.
    Kuna P.
    Clin Drug Investig; 2010 May; 30(9):565-79. PubMed ID: 20593912
    [Abstract] [Full Text] [Related]

  • 7. Inhaled steroid/long-acting beta 2 agonist combination products provide 24 hours improvement in lung function in adult asthmatic patients.
    Lötvall J, Langley S, Woodcock A.
    Respir Res; 2006 Aug 18; 7(1):110. PubMed ID: 16919161
    [Abstract] [Full Text] [Related]

  • 8. Onset of bronchodilation with fluticasone/formoterol combination versus fluticasone/salmeterol in an open-label, randomized study.
    Aalbers R, Brusselle G, McIver T, Grothe B, Bodzenta-Lukaszyk A.
    Adv Ther; 2012 Nov 18; 29(11):958-69. PubMed ID: 23081745
    [Abstract] [Full Text] [Related]

  • 9. Budesonide/formoterol maintenance and reliever therapy in Asian patients (aged ≥16 years) with asthma: a sub-analysis of the COSMOS study.
    Vogelmeier C, Naya I, Ekelund J.
    Clin Drug Investig; 2012 Jul 01; 32(7):439-49. PubMed ID: 22607479
    [Abstract] [Full Text] [Related]

  • 10. Switching from salmeterol/fluticasone to formoterol/budesonide combinations improves peripheral airway/alveolar inflammation in asthma.
    Akamatsu T, Shirai T, Kato M, Yasui H, Hashimoto D, Fujisawa T, Tsuchiya T, Inui N, Suda T, Chida K.
    Pulm Pharmacol Ther; 2014 Feb 01; 27(1):52-6. PubMed ID: 23583566
    [Abstract] [Full Text] [Related]

  • 11. Comparison of adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler and fixed-dose fluticasone propionate/salmeterol dry powder inhaler in asthma patients.
    Busse WW, Shah SR, Somerville L, Parasuraman B, Martin P, Goldman M.
    J Allergy Clin Immunol; 2008 Jun 01; 121(6):1407-14, 1414.e1-6. PubMed ID: 18455221
    [Abstract] [Full Text] [Related]

  • 12. Comparison of patient-reported outcomes during treatment with adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler versus fixed-dose fluticasone propionate/salmeterol dry powder inhaler in patients with asthma.
    O'Connor RD, Patrick DL, Parasuraman B, Martin P, Goldman M.
    J Asthma; 2010 Mar 01; 47(2):217-23. PubMed ID: 20170333
    [Abstract] [Full Text] [Related]

  • 13. Bronchodilator effect of an inhaled combination therapy with salmeterol + fluticasone and formoterol + budesonide in patients with COPD.
    Cazzola M, Santus P, Di Marco F, Boveri B, Castagna F, Carlucci P, Matera MG, Centanni S.
    Respir Med; 2003 May 01; 97(5):453-7. PubMed ID: 12735659
    [Abstract] [Full Text] [Related]

  • 14. Budesonide/formoterol for maintenance and relief in uncontrolled asthma vs. high-dose salmeterol/fluticasone.
    Bousquet J, Boulet LP, Peters MJ, Magnussen H, Quiralte J, Martinez-Aguilar NE, Carlsheimer A.
    Respir Med; 2007 Dec 01; 101(12):2437-46. PubMed ID: 17905575
    [Abstract] [Full Text] [Related]

  • 15. Acute care among asthma patients using budesonide/formoterol or fluticasone propionate/salmeterol.
    Blais L, Beauchesne MF, Forget A.
    Respir Med; 2009 Feb 01; 103(2):237-43. PubMed ID: 18930647
    [Abstract] [Full Text] [Related]

  • 16. Effect on lung function and morning activities of budesonide/formoterol versus salmeterol/fluticasone in patients with COPD.
    Partridge MR, Schuermann W, Beckman O, Persson T, Polanowski T.
    Ther Adv Respir Dis; 2009 Aug 01; 3(4):1-11. PubMed ID: 19734176
    [Abstract] [Full Text] [Related]

  • 17. Fixed or adjustable maintenance-dose budesonide/formoterol compared with fixed maintenance-dose salmeterol/fluticasone propionate in asthma patients aged >or=16 years: post hoc analysis of a randomized, double-blind/open-label extension, parallel-group study.
    Aalbers R.
    Clin Drug Investig; 2010 Aug 01; 30(7):439-51. PubMed ID: 20528000
    [Abstract] [Full Text] [Related]

  • 18. Emitted dose estimates from Seretide Diskus and Symbicort Turbuhaler following inhalation by severe asthmatics.
    Tarsin WY, Pearson SB, Assi KH, Chrystyn H.
    Int J Pharm; 2006 Jun 19; 316(1-2):131-7. PubMed ID: 16584855
    [Abstract] [Full Text] [Related]

  • 19. The bioavailability and airway clearance of the steroid component of budesonide/formoterol and salmeterol/fluticasone after inhaled administration in patients with COPD and healthy subjects: a randomized controlled trial.
    Dalby C, Polanowski T, Larsson T, Borgström L, Edsbäcker S, Harrison TW.
    Respir Res; 2009 Oct 31; 10(1):104. PubMed ID: 19878590
    [Abstract] [Full Text] [Related]

  • 20. Combination of budesonide/formoterol more effective than fluticasone/salmeterol in preventing exacerbations in chronic obstructive pulmonary disease: the PATHOS study.
    Larsson K, Janson C, Lisspers K, Jørgensen L, Stratelis G, Telg G, Ställberg B, Johansson G.
    J Intern Med; 2013 Jun 31; 273(6):584-94. PubMed ID: 23495860
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.